The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis.
The RASSF1A isoform of RASSF1 is frequently inactivated by epigenetic alterations in human cancers, but it remains unclear if and how it acts as a tumor suppressor. RASSF1A overexpression reduces in vitro colony formation and the tumorigenicity of cancer cell lines in vivo. Conversely, RASSF1A knockdown causes multiple mitotic defects that may promote genomic instability. Here, we have used a genetic approach to address the function of RASSF1A as a tumor suppressor in vivo by targeted deletion of Rassf1A in the mouse. Rassf1A null mice were viable and fertile and displayed no pathological abnormalities. Rassf1A null embryonic fibroblasts displayed an increased sensitivity to microtubule depolymerizing agents. No overtly altered cell cycle parameters or aberrations in centrosome number were detected in Rassf1A null fibroblasts. Rassf1A null fibroblasts did not show increased sensitivity to microtubule poisons or DNA-damaging agents and showed no evidence of gross genomic instability, suggesting that cellular responses to genotoxins were unaffected. Rassf1A null mice showed an increased incidence of spontaneous tumorigenesis and decreased survival rate compared with wild-type mice. Irradiated Rassf1A null mice also showed increased tumor susceptibility, particularly to tumors associated with the gastrointestinal tract, compared with wild-type mice. Thus, our results demonstrate that Rassf1A acts as a tumor suppressor gene.
van der Weyden
L
L
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom.
Tachibana
K K
KK
Gonzalez
M A
MA
Adams
D J
DJ
Ng
B L
BL
Petty
R
R
Venkitaraman
A R
AR
Arends
M J
MJ
Bradley
A
A
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D018385:Centrosome / Q000187:drug effects / Q000378:metabolism; D004249:DNA Damage; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D016147:Genes, Tumor Suppressor; D042822:Genomic Instability / Q000235:genetics; D008214:Lymphocytes / Q000502:physiology; D051379:Mice; D008817:Mice, Mutant Strains; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism*; D009369:Neoplasms / Q000235:genetics; D020033:Protein Isoforms / Q000235:genetics / Q000502:physiology; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000502:physiology*
D000970:Antineoplastic Agents; D020033:Protein Isoforms; C496882:RASSF1 protein, mouse; D025521:Tumor Suppressor Proteins